2006 Heart-Brain summit proceedings

Neurological mechanisms of chest pain and cardiac disease

Robert D. Foreman, PhD

Department of Physiology, University of Oklahoma Health Sciences Center
College of Medicine
Oklahoma City, OK

ARTICLE INTRODUCTION

Electrical stimulation of dorsal segments of the spinal cord has been used to treat patients with severe angina pectoris that is refractory to conventional therapies. The concept is based on the “gate control theory” first proposed by Melzack and Wall, in which a neuronal “gate” in the dorsal horn of the spinal cord controls the flow of noxious stimuli to the brain. Thus, spinal cord stimulation (SCS) can be thought of as “closing the gate” on pain. In the most often-used technique, an electrode is inserted over the dorsal columns and placed in the segments where electrical stimulation elicits paresthesias in the painful dermatomes. SCS activates large afferent fibers that have the ability to suppress stimuli from small fibers transmitting nociceptive information, and thereby “closes the pain gate.”

This article will briefly review the efficacy of SCS in relieving angina pectoris, provide an overview of the spinal processing of cardiac nociceptive information and the neural mechanisms of referred pain in the thoracic and cervical spinal cord, and examine the effects of SCS on the heart.

CITATIONS

  1. Melzack R, Wall PD.
    Pain mechanisms: a new theory. Science 1965; 150:971–979.
    http://www.ncbi.nlm.nih.gov/pubmed/5320816

  2. DeJongste MJ.
    Spinal cord stimulation for ischemic heart disease. Neurol Res 2000; 22:293–298.
    http://www.ncbi.nlm.nih.gov/pubmed/10769823
  3. Eliasson T, Augustinsson LE, Mannheimer C.
    Spinal cord stimulation in severe angina pectoris—presentation of current studies, indications and clinical experience. Pain 1996; 65:169–179.
    http://www.ncbi.nlm.nih.gov/pubmed/8826504
  4. Jessurun GA, DeJongste MJ, Blanksma PK.
    Current views on neurostimulation in the treatment of cardiac ischemic syndromes. Pain 1996; 66:109–116.
    http://www.ncbi.nlm.nih.gov/pubmed/8880831
  5. Andersen C, Hole P, Oxhoj H.
    Does pain relief with spinal cord stimulation for angina conceal myocardial infarction? Br Heart J 1994; 71:419–421.
    http://www.ncbi.nlm.nih.gov/pubmed/8011404
  6. De Jongste MJ, Haaksma J, Hautvast RW, et al.
    Effects of spinal cord stimulation on myocardial ischaemia during daily life in patients with severe coronary artery disease. A prospective ambulatory electrocardiographic study. Br Heart J 1994; 71:413–418.
    http://www.ncbi.nlm.nih.gov/pubmed/8011403
  7. Eliasson T, Jern S, Augustinsson LE, Mannheimer C.
    Safety aspects of spinal cord stimulation in severe angina pectoris. Coron Artery Dis 1994; 5:845–850.
    http://www.ncbi.nlm.nih.gov/pubmed/7866604
  8. Mannheimer C, Eliasson T, Andersson B, et al.
    Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. BMJ 1993; 307:477–480.
    http://www.ncbi.nlm.nih.gov/pubmed/8400930
  9. Linderoth B.
    Spinal cord stimulation in ischaemia and ischaemic pain: possible mechanisms of action. In: Horsch S, Blaey L, eds. Spinal Cord Stimulation. An Innovative Method in the Treatment of PVD and Angina. Darmstadt, Germany: Steinkopff Verlag; 1995:19–35.
  10. De Jongste MJ, Nagelkerke D, Hooyschuur CM, et al.
    Stimulation characteristics, complications, and efficacy of spinal cord stimulation systems in patients with refractory angina: a prospective feasibility study. Pacing Clin Electrophysiol 1994; 17:1751–1760.
    http://www.ncbi.nlm.nih.gov/pubmed/7838783
  11. Armour JA, Linderoth B, Arora RC, et al.
    Long-term modulation of the intrinsic cardiac nervous system by spinal cord neurons in normal and ischaemic hearts. Auton Neurosci 2002; 95:71–79.
    http://www.ncbi.nlm.nih.gov/pubmed/11873770
  12. Cardinal R, Ardell JL, Linderoth B, Vermeulen M, Foreman RD, Armour JA.
    Spinal cord activation differentially modulates ischaemic electrical responses to different stressors in canine ventricles. Auton Neurosci 2004; 111:37–47.
    http://www.ncbi.nlm.nih.gov/pubmed/15109937
  13. Cardinal R, Page P, Vermeulen M, et al.
    Spinal cord stimulation suppresses bradycardias and atrial tachyarrhythmias induced by mediastinal nerve stimulation in dogs. Am J Physiol Regul Integr Comp Physiol 2006; Jun 15 [Epub ahead of print].
    http://www.ncbi.nlm.nih.gov/pubmed/16778070
  14. Chandler MJ, Brennan TJ, Garrison DW, Kim KS, Schwartz PJ, Foreman RD.
    A mechanism of cardiac pain suppression by spinal cord stimulation: implications for patients with angina pectoris. Eur Heart J 1993; 14:96–105.
    http://www.ncbi.nlm.nih.gov/pubmed/8432300
  15. Foreman RD, Linderoth B, Ardell JL, et al.
    Modulation of intrinsic cardiac neurons by spinal cord stimulation: implications for its therapeutic use in angina pectoris. Cardiovasc Res 2000; 47:367–375.
    http://www.ncbi.nlm.nih.gov/pubmed/10946073
  16. Foreman RD, DeJongste MJL, Linderoth B.
    Integrative control of cardiac function by cervical and thoracic spinal neurons. In: Armour JA, Ardell JL, eds. Basic and Clinical Neurocardiology. New York: Oxford University Press; 2004:53–186.
  17. Foreman RD.
    Mechanisms of cardiac pain. Annu Rev Physiol 1999; 61:143–167.
    http://www.ncbi.nlm.nih.gov/pubmed/10099685
  18. Lindgren I, Olivecrona H.
    Surgical treatment of angina pectoris. J Neruosurg 1947; 4:19–39.
  19. White JC, Bland EF.
    The surgical relief of severe angina pectoris. Medicine (Baltimore) 1948; 27:1–42.
  20. Chandler MJ, Zhang J, Foreman RD.
    Vagal, sympathetic and somatic sensory inputs to upper cervical (C1-C3) spinothalamic tract neurons in monkeys. J Neurophysiol 1996; 76:2555–2567.
    http://www.ncbi.nlm.nih.gov/pubmed/8899627
  21. Chandler MJ, Zhang J, Qin C, Yuan Y, Foreman RD.
    Intrapericardiac injections of algogenic chemicals excite primate C1-C2 spinothalamic tract neurons. Am J Physiol Regul Integr Comp Physiol 2000; 279:R560–R568.
    http://www.ncbi.nlm.nih.gov/pubmed/10938246
  22. McNeill DL, Chandler MJ, Fu QG, Foreman RD.
    Projection of nodose ganglion cells to the upper cervical spinal cord in the rat. Brain Res Bull 1991; 27:151–155.
    http://www.ncbi.nlm.nih.gov/pubmed/1720704
  23. Jessurun GA, DeJongste MJ, Hautvast RW, et al.
    Clinical followup after cessation of chronic electrical neuromodulation in patients with severe coronary artery disease: a prospective randomized controlled study on putative involvement of sympathetic activity. Pacing Clin Electrophysiol 1999; 22:1432–1439.
    http://www.ncbi.nlm.nih.gov/pubmed/10588144
  24. Southerland EM, Milhorn DM, Foreman RD, et al.
    Pre-emptive, but not reactive, spinal cord stimulation mitigates transient ischemia induced myocardial infarction via cardiac adrenergic neurons. Am J Physiol Heart Circ Physiol 2006; Aug 18 [Epub ahead of print].
    http://www.ncbi.nlm.nih.gov/pubmed/16920800
  25. Maxwell MP, Hearse DJ, Yellon DM.
    Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987; 21:737–746.
    http://www.ncbi.nlm.nih.gov/pubmed/3440266
  26. Ardell JL, Yang X-M, Barron BA, Downey JM, Cohen MV.
    Endogenous myocardial norepineprhine is not essential for ischemic preconditioning in rabbit heart. Am J Physiol 1996; 270:H1078–H1084.
    http://www.ncbi.nlm.nih.gov/pubmed/8780206
  27. Bankwala Z, Hale SL, Kloner RA.
    Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. Circulation 1994; 90:1023–1028.
    http://www.ncbi.nlm.nih.gov/pubmed/8044915
  28. Marktanner R, Nacke P, Feindt P, Hohlfeld T, Gams E.
    Norepinephrine-induced delayed cardioprotection against stunning is at the expense of a higher postischemic arrhythmia rate. Cardiovasc Surg 2003; 11:475–482.
    http://www.ncbi.nlm.nih.gov/pubmed/14627970
  29. Stein AB, Tang X-L, Guo Y, Xuan Y-T, Dawn B, Bolli R.
    Delayed adaption of the heart to stress: late preconditioning. Stroke 2004; 35:2676–2679.
    http://www.ncbi.nlm.nih.gov/pubmed/15459441
  30. Thornton JD, Daly JF, Cohen MV, Yang X-M, Downey JM.
    Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ Res 1993; 73:649–655.
    http://www.ncbi.nlm.nih.gov/pubmed/8396502
  31. Ardell JL.
    Intrathoracic neuronal regulation of cardiac function. In: Armour JA, Ardell JL, eds. Basic and Clinical Neurocardiology. New York: Oxford University Press; 2004:118–152.
  32. Armour JA.
    Cardiac neuronal hierarchy in health and disease. Am J Physiol Regulatory Integrative Comp Physiol 2004; 287:R262–R271.
    http://www.ncbi.nlm.nih.gov/pubmed/15271675
  33. Dell’Italia LJ, Ardell JL.
    Sympathetic nervous system in the evolution of heart failure. In: Armour JA, Ardell JL, eds. Basic and Clinical Neurocardiology. New York: Oxford University Press; 2004:340–367.
  34. Tallaj J, Wei CC, Hankes GH, et al.
    _1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation. Circulation 2003; 108:225–230.
    http://www.ncbi.nlm.nih.gov/pubmed/12847066